 |
 |
janet paterson posted: > . . . . Catechol-O-methyltransferase (COMT, EC 2.1.1.6) is a > ubiquitous enzyme that is crucial to the metabolism of carcinogenic > catechols and catecholamines. . . . . What's this? Does the above imply that use of a COMT inhibitor, such as Tasmar, increases the risk of cancer? Phil Tompkins Hoboken NJ age 61/dx 1990